Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.35 - $15.21
Previous CloseN/A
Volume1.13M
Average Volume (3M)5.03M
Market Cap
$1.22B
Enterprise Value$1.64B
Total Cash (Recent Filing)$1.19B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Jul 29, 2025EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding175,434,770
10 Day Avg. Volume4,402,201
30 Day Avg. Volume5,033,289
Financial Highlights & Ratios
PEG Ratio1.80
Price to Book (P/B)0.87
Price to Sales (P/S)0.00
P/FCF Ratio5.96
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue0.16
Enterprise Value/Gross Profit0.96
Enterprise Value/Ebitda-0.67
Forecast
1Y Price Target
$8.46Price Target Upside16.37% Upside
Rating ConsensusHold
Number of Analyst Covering17
Teladoc News
Bulls Say, Bears Say
Bulls Say
Acquisition And Market StrategyThe acquisition of UpLift provides a solid pathway for in-network coverage in the BetterHelp segment, potentially offering affordability in an uncertain economic climate.
Financial PerformanceConsolidated revenue and adjusted EBITDA both exceeded analyst and consensus estimates, with notable outperformance in the Integrated Care segment.
Membership GrowthIntegrated Care membership grew nicely, up 12% to over 102.5MM members, representing potential cross-and upsell opportunities.
Bears Say
Contract Loss ImpactTeladoc expects chronic care enrollment in the second quarter to decline sequentially due to a previously discussed contract loss.
Enrollment DeclineLivongo MAUs in April declined 17.5% year over year, continuing mid-teens percentage point declines over the last 12 months.
Revenue DeclineAverage revenue per US Integrated Care Member fell 8.6% sequentially and 8.0% year-over-year, which could impact overall revenue growth.
Ownership Overview
0.56% Insiders
17.32% Mutual Funds
10.29% Other Institutional Investors
54.27% Public Companies and Individual Investors
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $6.35 and its highest was $15.21 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $1.22B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Jul 29, 2025 which is in 51 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Apr 30, 2025. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.343 by -$0.187.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.26.
How many shares outstanding does Teladoc have?
Teladoc has 175,434,770 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.343. Following the earnings report the stock price went down -2.782%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.46 (16.37% Upside)
$8.46 (16.37% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 237.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.08%
12-Months-Change
Fundamentals
Return on Equity
-54.49%
Trailing 12-Months
Asset Growth
-20.28%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive strategic developments such as the acquisition of UpLift, growth in the Integrated Care segment, and international success, but these were offset by financial challenges, including revenue decline, net losses, and macroeconomic concerns. The sentiment is balanced, reflecting both opportunities and challenges.Read More>TDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$8.46
▲(16.37%Upside)
Technical Analysis
National Healthcare
―
Phreesia
―
Arcutis Biotherapeutics
―
Schrodinger
―
Enliven Therapeutics
―